Skip to main content

Meaningful Life

Dear readers,

We have a wealth of information on the internet on how to live a meaningful life and mantras to obtain desired results.

Meaning of living a purposeful life is different for each individual. Each one's stake is different in life. In other words, we can say the purpose and intention of living a meaningful life are dependent on one's inner built and measure of happiness. For some it is about building purposeful connections; for some, it is about having wealth in life whereas for some it could be entirely different.

For me, the definition of living a meaningful life does not come without putting myself first on top of my priority list. I have to be able to carve time for myself, be able to take care of my needs, priorities and extend this definition next to my close family members and friends.

With that said, a good, healthy lifestyle has lately become a big focus of my agenda on a daily basis. Paying attention to what I eat, how much I eat, what I do to keep myself healthy in terms of the nutritious value of the food as well as exercise is on top of my list.

Additionally, keeping stress levels under control is considered to be very important. This could be as important as eating nutritious food.  Keeping stress under control is something that does not come easy and needs practice especially when everyone has so much to get done on a daily basis. Stress might cause chronic inflammation that could lead to an unhealthy life if stays unaddressed long-term.

I am starting this blog to learn and educate myself as well as share my learnings with anyone interested in the topic. I will focus on many different ways to manage and control stress. To practice certain things as routine to be able to at least reduce stress. It might be eating a certain type of foods, supplements or practice of mindfulness!

Comments

Post a Comment

Popular posts from this blog

Group C (Treatment IND) Drugs

BayBiotech.NET Since 1976, National Cancer Institute (NCI) in agreement with FDA has established the Group C classification system to allow access to certain drugs for the cancer patients specifically falling under a category that adequate alternative therapy or if the available alternative therapy has significant toxic effects. Each Group C drug protocol specifies patient eligibility and drug use information. Group C drugs are provided only to properly trained physicians who have registered themselves with NCI using a special form to assure that their patient qualifies under guidelines - or protocols - for the drug. Physicians using drugs under Group C have no reporting requirements to the NCI other than the obligation to report adverse drug reactions. Group C drugs are provided free of charge, and the Centers for Medicare and Medicaid Services provides coverage for care associated with Group C therapy. Making Group C drugs available to the critically ill patients not only provi...
Post a Comment
Read more

Good Machine Learning Practices

BayBiotech.NET A joint effort by FDA,  United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) and Health Canada have developed guiding principles to help promote utilization of medical devices that are safe and effective and utilize artiificial intelligence and machine learning. To find out more details check out the link here!
Post a Comment
Read more

Harmonization by Doing (HBD): Japan & U.S. Collaboration

BayBiotech.NET HBD is an international cooperative effort by Japan and US for regulatory convergence for Medical Devices. The efforts are focused on to develop global clinical trials and address regulatory barriers for timely device approvals. To address the needs for additional evaluation, the HBD initiative is a pilot project launched jointly by FDA and MHLW-PMDA for the premarket review of device cardiovascular technology. Instead of taking a theoretical approach to harmonization, HBD is focused on Proof of concept by utilizing parallel development, application submissions and review of actual medical device projects. HBD Study intends to collect and analyze regulatory submission data from multiple applications in the U.S. and Japan. The purpose of the study is to further understand differences that may exist with format and content, to define best practices and to improve globally harmonized processes. To read more about the HBD program, follow the link: http://www.fda.gov/M...
Post a Comment
Read more